Identification of Spiro-Fused Pyrrolo[3,4-<i>a</i>]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation

A series of heterocyclic compounds containing a spiro-fused pyrrolo[3,4-<i>a</i>]pyrrolizine and tryptanthrin framework have been synthesized and studied as potential antitumor agents. Cytotoxicity of products was screened against human erythroleukemia (K562) and human cervical carcinoma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Diana K. Latypova, Stanislav V. Shmakov, Sofya A. Pechkovskaya, Alexander S. Filatov, Alexander V. Stepakov, Nickolay A. Knyazev, Vitali M. Boitsov
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/93d8c4d3ad054ca4a3382215286f5fee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:93d8c4d3ad054ca4a3382215286f5fee
record_format dspace
spelling oai:doaj.org-article:93d8c4d3ad054ca4a3382215286f5fee2021-11-11T17:24:46ZIdentification of Spiro-Fused Pyrrolo[3,4-<i>a</i>]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation10.3390/ijms2221119971422-00671661-6596https://doaj.org/article/93d8c4d3ad054ca4a3382215286f5fee2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11997https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067A series of heterocyclic compounds containing a spiro-fused pyrrolo[3,4-<i>a</i>]pyrrolizine and tryptanthrin framework have been synthesized and studied as potential antitumor agents. Cytotoxicity of products was screened against human erythroleukemia (K562) and human cervical carcinoma (HeLa) cell lines. Among the screened compounds. <b>4a</b>, <b>4b</b> and <b>5a</b> were active against human erythroleukemia (K562) cell line, while <b>4a</b> and <b>5a</b> were active against cervical carcinoma (HeLa) cell line. In agreement with the DNA cytometry studies, the tested compounds have achieved significant cell-cycle perturbation with higher accumulation of cells in G2/M phase and induced apoptosis. Using confocal microscopy, we found that with <b>4a</b> and <b>5a</b> treatment of HeLa cells, actin filaments disappeared, and granular actin was distributed diffusely in the cytoplasm in 76–91% of cells. We discovered that HeLa cells after treatment with compounds <b>4a</b> and <b>5a</b> significantly reduced the number of cells with filopodium-like membrane protrusions (from 63 % in control cells to 29% after treatment) and a decrease in cell motility.Diana K. LatypovaStanislav V. ShmakovSofya A. PechkovskayaAlexander S. FilatovAlexander V. StepakovNickolay A. KnyazevVitali M. BoitsovMDPI AGarticleone-pot synthesis1,3-dipolar cycloadditiontryptanthrin-derived azomethine ylidepyrrolo[3,4-<i>a</i>]pyrrolizinetumor cellsantiproliferative activityBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11997, p 11997 (2021)
institution DOAJ
collection DOAJ
language EN
topic one-pot synthesis
1,3-dipolar cycloaddition
tryptanthrin-derived azomethine ylide
pyrrolo[3,4-<i>a</i>]pyrrolizine
tumor cells
antiproliferative activity
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle one-pot synthesis
1,3-dipolar cycloaddition
tryptanthrin-derived azomethine ylide
pyrrolo[3,4-<i>a</i>]pyrrolizine
tumor cells
antiproliferative activity
Biology (General)
QH301-705.5
Chemistry
QD1-999
Diana K. Latypova
Stanislav V. Shmakov
Sofya A. Pechkovskaya
Alexander S. Filatov
Alexander V. Stepakov
Nickolay A. Knyazev
Vitali M. Boitsov
Identification of Spiro-Fused Pyrrolo[3,4-<i>a</i>]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation
description A series of heterocyclic compounds containing a spiro-fused pyrrolo[3,4-<i>a</i>]pyrrolizine and tryptanthrin framework have been synthesized and studied as potential antitumor agents. Cytotoxicity of products was screened against human erythroleukemia (K562) and human cervical carcinoma (HeLa) cell lines. Among the screened compounds. <b>4a</b>, <b>4b</b> and <b>5a</b> were active against human erythroleukemia (K562) cell line, while <b>4a</b> and <b>5a</b> were active against cervical carcinoma (HeLa) cell line. In agreement with the DNA cytometry studies, the tested compounds have achieved significant cell-cycle perturbation with higher accumulation of cells in G2/M phase and induced apoptosis. Using confocal microscopy, we found that with <b>4a</b> and <b>5a</b> treatment of HeLa cells, actin filaments disappeared, and granular actin was distributed diffusely in the cytoplasm in 76–91% of cells. We discovered that HeLa cells after treatment with compounds <b>4a</b> and <b>5a</b> significantly reduced the number of cells with filopodium-like membrane protrusions (from 63 % in control cells to 29% after treatment) and a decrease in cell motility.
format article
author Diana K. Latypova
Stanislav V. Shmakov
Sofya A. Pechkovskaya
Alexander S. Filatov
Alexander V. Stepakov
Nickolay A. Knyazev
Vitali M. Boitsov
author_facet Diana K. Latypova
Stanislav V. Shmakov
Sofya A. Pechkovskaya
Alexander S. Filatov
Alexander V. Stepakov
Nickolay A. Knyazev
Vitali M. Boitsov
author_sort Diana K. Latypova
title Identification of Spiro-Fused Pyrrolo[3,4-<i>a</i>]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation
title_short Identification of Spiro-Fused Pyrrolo[3,4-<i>a</i>]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation
title_full Identification of Spiro-Fused Pyrrolo[3,4-<i>a</i>]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation
title_fullStr Identification of Spiro-Fused Pyrrolo[3,4-<i>a</i>]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation
title_full_unstemmed Identification of Spiro-Fused Pyrrolo[3,4-<i>a</i>]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation
title_sort identification of spiro-fused pyrrolo[3,4-<i>a</i>]pyrrolizines and tryptanthrines as potential antitumor agents: synthesis and in vitro evaluation
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/93d8c4d3ad054ca4a3382215286f5fee
work_keys_str_mv AT dianaklatypova identificationofspirofusedpyrrolo34iaipyrrolizinesandtryptanthrinesaspotentialantitumoragentssynthesisandinvitroevaluation
AT stanislavvshmakov identificationofspirofusedpyrrolo34iaipyrrolizinesandtryptanthrinesaspotentialantitumoragentssynthesisandinvitroevaluation
AT sofyaapechkovskaya identificationofspirofusedpyrrolo34iaipyrrolizinesandtryptanthrinesaspotentialantitumoragentssynthesisandinvitroevaluation
AT alexandersfilatov identificationofspirofusedpyrrolo34iaipyrrolizinesandtryptanthrinesaspotentialantitumoragentssynthesisandinvitroevaluation
AT alexandervstepakov identificationofspirofusedpyrrolo34iaipyrrolizinesandtryptanthrinesaspotentialantitumoragentssynthesisandinvitroevaluation
AT nickolayaknyazev identificationofspirofusedpyrrolo34iaipyrrolizinesandtryptanthrinesaspotentialantitumoragentssynthesisandinvitroevaluation
AT vitalimboitsov identificationofspirofusedpyrrolo34iaipyrrolizinesandtryptanthrinesaspotentialantitumoragentssynthesisandinvitroevaluation
_version_ 1718432132702928896